Business Context and Reporting Period
This Form 8-K filing by Palisade Bio, Inc. (PALI) reports on events occurring on December 3, 2025. The filing details the results of a Special Meeting of Stockholders held on that date and the subsequent filing of a Certificate of Amendment with the State of Delaware.
Key Financial Metrics
This filing is a current report regarding corporate governance and capital structure changes. It does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing text does not provide a clear value for any financial performance indicators.
Material Changes and Corporate Actions
- Authorized Share Increase: Stockholders approved an amendment to the Amended and Restated Certificate of Incorporation, increasing the total number of authorized common shares from 280,000,000 to 300,000,000. The total authorized capital stock increased from 287,000,000 to 307,000,000 shares.
- Warrant Exercise Approval: Stockholders approved the issuance of up to 8,637,810 shares of common stock underlying warrants issued under a July 23, 2025, warrant inducement agreement. This issuance exceeds 20% of the common stock outstanding prior to the warrant issuance, requiring stockholder approval under Nasdaq Listing Rule 5635(d).
- Meeting Participation: As of the October 17, 2025 record date, 148,964,572 shares were outstanding. Approximately 85.53% of outstanding shares (127,404,008 shares) were present in person or by proxy, constituting a quorum.
Voting Results Summary
| Proposal | Votes For | Votes Against | Withheld/Abstentions | Broker Non-Votes |
|---|---|---|---|---|
| 1. Warrant Exercise Proposal | 104,727,000 | 247,103 | 10,386 | 22,419,519 |
| 2. Amendment to Increase Authorized Shares | 126,272,110 | 1,095,166 | 36,732 | — |
| 3. Adjournment Proposal | 126,487,729 | 867,738 | 48,541 | — |
Guidance, Outlook, and Risks
The filing does not provide management commentary on future financial guidance, operational outlook, or specific risk factors beyond the standard disclosure that the description of the Amendment is qualified by reference to the full text of the Amendment (Exhibit 3.1). No unusual items or contingencies were disclosed in this report.
Key Facts for Investor Verification
- Verify the effective date of the Certificate of Amendment filed with the Delaware Secretary of State (effective upon filing on December 3, 2025).
- Confirm the terms of the July 23, 2025, warrant inducement agreement to understand the conditions under which the 8,637,810 shares may be issued.
- Review the impact of the increased authorized share count (300,000,000) on potential future dilution and capital raising capacity.
- Note the significant number of broker non-votes (22.4 million) on the Warrant Exercise Proposal, indicating brokers did not have discretionary voting power on this specific matter.